NASDAQ$HELE

Helen of Troy Limited · Q3 2025 earnings

Q3 2025 earnings · · Investor relations

Briefing

Helen of Troy's performance was within expectations amidst a challenging consumer environment, marked by growth in Home & Outdoor and International segments but impacted by a weak illness season in Beauty & Wellness. The acquisition of Olive & June enhanced the portfolio, and Project Pegasus remained on track.

Helen of Troy reported a 3.4% decrease in consolidated net sales revenue to $530.7 million. GAAP diluted EPS was $2.17, while adjusted diluted EPS was $2.67. The company saw gross profit margin expansion of 90 basis points and adjusted operating margin expansion of 30 basis points. The acquisition of Olive & June was completed subsequent to the quarter's end.

  • Consolidated net sales decreased by 3.4% to $530.7 million.
  • Gross profit margin improved by 90 basis points to 48.9%.
  • GAAP diluted EPS was $2.17, compared to $3.19 in the prior year.
  • Adjusted diluted EPS decreased to $2.67 from $2.79 year-over-year.

Headline financials

Total Revenue

$531M

Previous: $549M-3.3%
EPS (adj)

$2.67

Previous: $2.79-4.3%
Adjusted EBITDA

$96.8M

No prior period
Gross profit margin

48.9%

No prior period
Operating margin

14.2%

No prior period
Adjusted operating margin

16.6%

No prior period
Adjusted EBITDA margin

18.2%

No prior period
Interest expense

$12.2M

No prior period
Accounts receivable turnover

72.3

No prior period
Capital Expenditures

-$8.13M

Previous: -$9.12M+10.9%
Net Income

$49.6M

Previous: $75.9M-34.6%
Operating Income

$75.1M

Previous: $107M-29.7%
Gross Profit

$259M

Previous: $264M-1.7%
Stock-Based Comp

$4.73M

Previous: $8.58M-44.9%

Revenue & EPS history

Helen of Troy · Revenue · Quarterly

$531M

Q3 2025-3.3%vs Q3 2024
Beat estimate in 12 of 14 quarters(86%)
ActualEstimate

Forward guidance

The company expects consolidated net sales revenue in the range of $1.888 billion to $1.913 billion, GAAP diluted EPS of $4.60 to $5.02, and non-GAAP adjusted diluted EPS in the range of $7.15 to $7.40. Adjusted EBITDA is expected to be $292 million to $295 million, and free cash flow is projected to be $145 million to $155 million.

Tailwinds

  • Includes an expected incremental net sales contribution of $17 million to $18 million from the Olive & June acquisition.
  • Adjusted EPS accretion from the Olive & June acquisition in the range of $0.05 to $0.07 in the fourth quarter of fiscal year 2025.
  • Adjusted EBITDA in the range of $3 million to $4 million from the Olive & June acquisition.
  • Automation system began to operate as designed during the third quarter of fiscal 2025 and the Company expects to achieve targeted efficiency levels by the end of fiscal 2025.
  • Benefits from Project Pegasus are reinvested for growth.

Headwinds

  • Consolidated net sales revenue decline of 5.8% to 4.6%.
  • Revised expectations for a weak winter and illness season globally, estimated to be $25 million to $30 million for the full fiscal year and $15 million to $20 million in the fourth quarter of fiscal year 2025.
  • Lingering inflation and continued consumer spending softness, especially in certain discretionary categories.
  • Increased macro uncertainty, an increasingly stretched consumer, a more promotional environment, and retailers even more closely managing their inventory levels.
  • Margin compression of approximately 50 basis points from incremental operating expense and lost efficiency related to automation startup issues at its Tennessee distribution facility.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q3 2025

Historical avgQ3 2025

-0.2%

Avg return

Earnings day

-1.4%

Avg return

5 days after

-1.5%

Avg return

30 days after

37%

24 / 65 earnings

Positive

+25.6%

Q4 2019

Best reaction

-30.6%

Q1 2025

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q4 2026+20.5%+18.6%+29.8%
Q3 2026-2.4%-11.4%-11.0%
Q2 2026-24.6%-24.9%-29.7%
Q1 2026-7.6%+1.1%+8.6%
Q4 2025-12.0%-16.7%-23.1%
Q3 2025+4.5%+3.3%-5.0%
Q2 2025+16.0%+9.8%+0.2%
Q1 2025-30.6%-28.0%-38.2%
Q4 2024-9.4%-7.9%+4.5%
Q3 2024+8.0%+4.7%-2.1%
Q2 2024-5.7%-4.9%-9.7%
Q1 2024+15.1%+14.1%+19.6%
Q4 2023+17.8%-1.4%+11.6%
Q3 2023-1.4%-1.0%+6.4%
Q2 2023+1.8%-1.9%-13.7%
Q1 2023-9.6%-19.7%-23.5%
Q4 2022+6.0%-0.7%-11.4%
Q3 2022-3.5%-5.1%-15.3%
Q2 2022+3.8%+1.3%+8.1%
Q1 2022-7.4%-10.0%-2.6%
Q4 2021-5.5%-2.8%-5.9%
Q3 2021-6.3%-5.6%+0.4%
Q2 2021-3.4%-1.6%+1.5%
Q1 2021+3.8%+4.7%+3.2%
Q4 2020+7.5%+11.1%+20.1%
Q3 2020+3.7%+0.7%+5.7%
Q2 2020-5.9%-2.7%-3.8%
Q1 2020+10.4%+11.1%+11.9%
Q4 2019+25.6%+22.2%+16.2%
Q3 2019-15.9%-14.5%-13.4%
Q2 2019-2.7%-3.1%+9.5%
Q1 2019+14.9%+12.8%+10.5%
Q4 2018+5.6%+6.0%+6.9%
Q3 2018+0.0%+1.4%-6.5%
Q2 2018-11.0%-8.4%-11.0%
Q1 2018-5.3%-1.1%+6.4%
Q4 2017-3.0%-3.4%-7.2%
Q3 2017+9.6%+6.6%+6.2%
Q2 2017-6.7%-7.2%-7.6%
Q1 2017-3.8%-2.4%-6.3%
Q4 2016-2.8%
Q3 2016-0.9%
Q2 2016+6.9%
Q1 2016-11.3%
Q4 2015+11.6%
Q3 2015+15.3%
Q2 2015-0.1%
Q1 2015-3.0%
Q4 2014-4.8%
Q3 2014+10.9%
Q2 2014+2.8%
Q1 2014+4.7%
Q4 2013-2.3%
Q3 2013+7.8%
Q2 2013-10.1%
Q1 2012-7.6%
Q1 2013-7.6%
Q4 2010-1.6%
Q1 2011-1.6%
Q4 2012-1.6%
Q3 2011-1.5%
Q3 2012-1.5%
Q2 2012-1.0%
Q2 2011-1.0%
Q4 2011-1.0%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro